Skip to content

Inogen INGN Investment Purchases

Investment Purchases at other companies

ResMed logo
ResMedRMD
$20.13M+881%
Pulmonx Corporation logo
Pulmonx CorporationLUNG
$0-100%
Savara logo
SavaraSVRA
$127.24M+297%

Other financials

Income statement

See full
Revenue$85.1M+3.4%
Gross profit$44.9M+1.7%
Operating income-$9.3M-21.9%
Net income-$8.3M-34.8%
EPS (diluted)-$0.30-20.0%

Balance sheet

See full
Cash & equivalents$93.1M-21.7%
Total debt$16.9M-11.9%
Total equity$182.9M-7.6%
Total assets$285.9M-7.3%

Cash flow

See full
Operating cash flow-$6.7M+60.2%
CapEx$210.0K-28.1%
Free cash flow-$6.9M+59.6%

Valuation

See full
Market cap$174.63M-9.7%
Enterprise value$98.45M-9.5%
P/S0.5×-0.1×

Profitability

See full
Gross margin52.8%-2.6pp
Operating margin-9.1%-0.8pp
Net margin-7.1%-0.8pp
FCF margin0.4%

Returns & leverage

See full
Return on equity-13.1%-0.9pp
Debt / equity0.1×0.0×
Current ratio3.1×0.0×

Where this comes from

Reported directly by Inogen in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt.

The official record: Inogen’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Inogen's investment purchases.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Inogen's investment purchases?
Inogen (INGN) reported investment purchases of $5.86M in Q1 2026.
What is the long-term trend for Inogen's investment purchases?
Over 2 years (2021 to 2024), Inogen's investment purchases has grown at a 80.8% compound annual growth rate (CAGR), from $9.99M to $32.66M.
What does investment purchases mean?
Cash spent purchasing investment securities across all categories.